Advertisement

Radiology

  • Christian MaaserEmail author
  • Kerri Novak
Chapter

Abstract

It is well known and recognized that relying solely on the clinical symptoms at initial diagnosis as well as during the cause of the disease in the symptomatic and also asymptomatic patients bares the danger of under- as well as overtreating as symptoms often do not reflect the current disease status. Therefore, at different time points of the disease, specific attention must be given to various imaging modalities to optimize the IBD treatment. The following chapter will focus on the different imaging options and suggest algorithms on when to apply which method.

Keywords

Imaging Intestinal ultrasound Endoscopy Magnetic resonance enterography Pelvic MR 

References

  1. af Björkesten C-G, Nieminen U, Turunen U, Arkkila P, Sipponen T, Färkkilä M (2012) Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn’s disease. Scand J Gastroenterol 47(5):528–537CrossRefGoogle Scholar
  2. Al-Hawary MM, Zimmermann EM, Hussain HK (2014) MR imaging of the small bowel in Crohn disease. Magn Reson Imaging Clin N Am 22(1):13–22.  https://doi.org/10.1016/j.mric.2013.09.001 CrossRefPubMedGoogle Scholar
  3. Allen BC, Leyendecker JR (2014) MR enterography for assessment and management of small bowel Crohn disease. Radiol Clin N Am 52(4):799–810CrossRefGoogle Scholar
  4. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB et al (2003) Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A 100(24):13761–13766CrossRefGoogle Scholar
  5. Calabrese E, Zorzi F, Onali S, Stasi E, Fiori R, Prencipe S et al (2013) Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with crohn’s disease. Clin Gastroenterol Hepatol 11(8):950–955.  https://doi.org/10.1016/j.cgh.2013.01.015 CrossRefPubMedGoogle Scholar
  6. Calabrese E, Maaser C, Zorzi F, Kannengiesser K, Hanauer SB, Bruining DH et al (2016) Bowel ultrasonography in the management of Crohnʼs disease. A review with recommendations of an international panel of experts. Inflamm Bowel Dis 22(5):1168–1183CrossRefGoogle Scholar
  7. Estay C, Simian D, Lubascher J, Figueroa C, O’Brien A, Quera R (2015) Ionizing radiation exposure in patients with inflammatory bowel disease: are we overexposing our patients? J Dig Dis 16(2):83–89CrossRefGoogle Scholar
  8. Greenup A, Bressler B, Rosenfeld G (2016) Medical imaging in small bowel Crohn’s disease-computer tomography enterography, magnetic resonance enterography, and ultrasound: “which one is the best for what?”. Inflamm Bowel Dis 22(5):1246–1261CrossRefGoogle Scholar
  9. Horsthuis K, Bipat S, Bennink R, Stoker J (2008) Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 247(1):64–79CrossRefGoogle Scholar
  10. Kroeker KI, Lam S, Birchall I, Fedorak RN (2011) Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol 45(1):34–39CrossRefGoogle Scholar
  11. Maconi G, Tonolini M, Monteleone M, Bezzio C, Furfaro F, Villa C et al (2013) Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn’s disease. Inflamm Bowel Dis 19(13):2737–2743CrossRefGoogle Scholar
  12. Kucharzik T, Maaser C. (2018) Intestinal ultrasound and management of small bowel Crohn´s disease. Therap Adv Gastroenterol. 11:1756284818771367CrossRefGoogle Scholar
  13. Novak K, Tanyingoh D, Petersen F, Kucharzik T, Panaccione R, Ghosh S et al (2015) Clinic-based point of care transabdominal ultrasound for monitoring Crohn’s disease: impact on clinical decision making. J Crohns Colitis 9(9):795–801.  https://doi.org/10.1093/ecco-jcc/jjv105 CrossRefPubMedGoogle Scholar
  14. Nylund K, Maconi G, Hollerweger A, Ripolles T, Pallotta N, Higginson A et al (2017) EFSUMB recommendations and guidelines for gastrointestinal ultrasound. Ultraschall Med 38(3):e1–e15.  https://doi.org/10.1055/s-0042-115853 CrossRefPubMedGoogle Scholar
  15. Ordás I, Rimola J, Rodríguez S, Paredes JM, Martínez-Pérez MJ, Blanc E et al (2014) Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 146(2):374–82.e1CrossRefGoogle Scholar
  16. Pallotta N, Vincoli G, Montesani C, Chirletti P, Pronio A, Caronna R et al (2012) Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in Crohnʼs disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis 18(1):74–84.  https://doi.org/10.1002/ibd.21678 CrossRefPubMedGoogle Scholar
  17. Panés J, Bouzas R, Chaparro M, García-Sánchez V, Gisbert JP, Martínez de Guereñu B et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34(2):125–145CrossRefGoogle Scholar
  18. Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7(7):556–585CrossRefGoogle Scholar
  19. Papay P, Ignjatovic A, Karmiris K, Amarante H, Miheller P, Feagan B, et al (2013) Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis 7(8):653–669. http://www.sciencedirect.com/science/article/pii/S1873994613000706 CrossRefGoogle Scholar
  20. Quon JS, Quon PR, Lim CS, Abdeen N, Schieda N (2015) Magnetic resonance enterography in post-operative inflammatory bowel disease. Abdom Imaging 40(5):1034–1049.  https://doi.org/10.1007/s00261-015-0392-1 CrossRefPubMedGoogle Scholar
  21. Rimola J, Ordás I, Rodriguez S, García-Bosch O, Aceituno M, Llach J et al (2011) Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 17(8):1759–1768CrossRefGoogle Scholar
  22. Sandborn WJ, Hanauer S, Van Assche G, Panés J, Wilson S, Petersson J et al (2014) Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases. J Crohns Colitis 8(9):927–935CrossRefGoogle Scholar
  23. Solem CA, Loftus EV, Fletcher JG, Baron TH, Gostout CJ, Petersen BT et al (2008) Small-bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 68(2):255–266CrossRefGoogle Scholar
  24. Taylor SA, Avni F, Cronin CG, Hoeffel C, Kim SH, Laghi A et al (2017) The first joint ESGAR/ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging. Eur Radiol 27(6):2570–2582CrossRefGoogle Scholar
  25. Villa C, Pompili G, Franceschelli G, Munari A, Radaelli G, Maconi G et al (2012) Role of magnetic resonance imaging in evaluation of the activity of perianal Crohn’s disease. Eur J Radiol 81(4):616–622CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Ambulanzzentrum Gastroenterologie am Klinikum LueneburgLueneburgGermany
  2. 2.Division of Gastroenterology and Hepatology, Department of MedicineUniversity of CalgaryCalgaryCanada

Personalised recommendations